Next Article in Journal
Impact of Immunosuppressants and Vaccination on COVID-19 Outcomes in Autoimmune Patients and Solid Organ Transplant Recipients: A Nationwide Propensity Score-Matched Study
Previous Article in Journal
Partial Protection of Goats against Haemonchus contortus Achieved with ADP-Ribosylation Factor 1 Encapsulated in PLGA Nanoparticles
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 12
Issue 10
10.3390/vaccines12101189
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Vaccines 2024, 12(8), 874.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874

by
Dominik A. Rothen
1,2,3,*,
Sudip Kumar Dutta
4,
Pascal S. Krenger
1,2,3,
Anne-Cathrine S. Vogt
1,2,3,
Ilva Lieknina
5,
Jan M. Sobczak
1,2,3,
Albert D. M. E. Osterhaus
6,
Mona O. Mohsen
1,2,
Monique Vogel
1,2,
Byron Martina
4,
Kaspars Tars
5 and
Martin F. Bachmann
1,2,7
1
Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland
2
Department of Immunology RIA, University Hospital Bern, 3010 Bern, Switzerland
3
Graduate School of Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland
4
Artemis Bioservices, 2629 JD Delft, The Netherlands
5
Latvian Biomedical Research & Study Centre, Ratsupites iela 1, LV 1067 Riga, Latvia
6
Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Germany
7
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK
*
Author to whom correspondence should be addressed.
Vaccines 2024, 12(10), 1189; https://doi.org/10.3390/vaccines12101189
Submission received: 7 October 2024 / Accepted: 10 October 2024 / Published: 18 October 2024
Browse Figure
Versions Notes
The authors would like to make the following corrections to this published paper [1].
In the original manuscript, Figure 10A contained an error in the labeling of the X-axis (Log Dilution). The correct dilutions used for the serum were from 1/20 to 1/160, which correspond to log dilutions approximately from log 1.3 to log 2.2. Therefore, the X-axis should have been labeled as 1.2 to 2.4, rather than 2.2 to 3.4. We apologize for this oversight and have corrected the figure accordingly to reflect the accurate dilution range. The corrected Figure 10 is listed below:
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Rothen, D.A.; Dutta, S.K.; Krenger, P.S.; Vogt, A.-C.S.; Lieknina, I.; Sobczak, J.M.; Osterhaus, A.D.M.E.; Mohsen, M.O.; Vogel, M.; Martina, B.; et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874. [Google Scholar] [CrossRef]
Vaccines 12 01189 g010
Figure 10. Antibodies induced by vaccination with DV1-AP205/AP205-DV4 do not enhance DENV−2 infection. (A) Fold change of DENV-2 infection of the serum-induced by vaccination with DV1-AP205/AP205-DV4. Day 28 is shown in black, and day 49 is shown in grey. Negative Control (naïve serum) is shown in blue. The serum dilution is shown in log values. (B) Fold change of DENV-2 infection of mouse 4G2 antibody used as a positive control. Antibody concentration is shown in log values. Statistical analysis (mean ± SEM) using one-way ANOVA. Vaccine group n = 6. One representative of two similar experiments is shown. The value of p < 0.05 was considered statistically significant (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Figure 10. Antibodies induced by vaccination with DV1-AP205/AP205-DV4 do not enhance DENV−2 infection. (A) Fold change of DENV-2 infection of the serum-induced by vaccination with DV1-AP205/AP205-DV4. Day 28 is shown in black, and day 49 is shown in grey. Negative Control (naïve serum) is shown in blue. The serum dilution is shown in log values. (B) Fold change of DENV-2 infection of mouse 4G2 antibody used as a positive control. Antibody concentration is shown in log values. Statistical analysis (mean ± SEM) using one-way ANOVA. Vaccine group n = 6. One representative of two similar experiments is shown. The value of p < 0.05 was considered statistically significant (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Vaccines 12 01189 g010
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rothen, D.A.; Dutta, S.K.; Krenger, P.S.; Vogt, A.-C.S.; Lieknina, I.; Sobczak, J.M.; Osterhaus, A.D.M.E.; Mohsen, M.O.; Vogel, M.; Martina, B.; et al. Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874. Vaccines 2024, 12, 1189. https://doi.org/10.3390/vaccines12101189

AMA Style

Rothen DA, Dutta SK, Krenger PS, Vogt A-CS, Lieknina I, Sobczak JM, Osterhaus ADME, Mohsen MO, Vogel M, Martina B, et al. Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874. Vaccines. 2024; 12(10):1189. https://doi.org/10.3390/vaccines12101189

Chicago/Turabian Style

Rothen, Dominik A., Sudip Kumar Dutta, Pascal S. Krenger, Anne-Cathrine S. Vogt, Ilva Lieknina, Jan M. Sobczak, Albert D. M. E. Osterhaus, Mona O. Mohsen, Monique Vogel, Byron Martina, and et al. 2024. "Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874" Vaccines 12, no. 10: 1189. https://doi.org/10.3390/vaccines12101189

APA Style

Rothen, D. A., Dutta, S. K., Krenger, P. S., Vogt, A. -C. S., Lieknina, I., Sobczak, J. M., Osterhaus, A. D. M. E., Mohsen, M. O., Vogel, M., Martina, B., Tars, K., & Bachmann, M. F. (2024). Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874. Vaccines, 12(10), 1189. https://doi.org/10.3390/vaccines12101189

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop